Susan E. Yost

1.7k total citations
71 papers, 896 citations indexed

About

Susan E. Yost is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Susan E. Yost has authored 71 papers receiving a total of 896 indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Oncology, 27 papers in Pulmonary and Respiratory Medicine and 23 papers in Molecular Biology. Recurrent topics in Susan E. Yost's work include Advanced Breast Cancer Therapies (21 papers), Cancer Immunotherapy and Biomarkers (17 papers) and Cancer Genomics and Diagnostics (9 papers). Susan E. Yost is often cited by papers focused on Advanced Breast Cancer Therapies (21 papers), Cancer Immunotherapy and Biomarkers (17 papers) and Cancer Genomics and Diagnostics (9 papers). Susan E. Yost collaborates with scholars based in United States, United Kingdom and Saudi Arabia. Susan E. Yost's co-authors include Yuan Yuan, Jin Sun Lee, Joanne Mortimer, Paul Frankel, Daniel Schmolze, Anna V. Hoekstra, Michael J. Corbel, Ross C. Hardison, Brian M. Shewchuk and Colt A. Egelston and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Susan E. Yost

69 papers receiving 888 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Susan E. Yost United States 18 458 305 241 221 134 71 896
Tetsuhiko Asao Japan 18 369 0.8× 309 1.0× 226 0.9× 160 0.7× 124 0.9× 66 932
Wenzheng Guo China 19 272 0.6× 580 1.9× 124 0.5× 251 1.1× 140 1.0× 35 975
Colt A. Egelston United States 15 489 1.1× 274 0.9× 141 0.6× 192 0.9× 645 4.8× 39 1.1k
Arnold I. Chin United States 14 192 0.4× 389 1.3× 236 1.0× 233 1.1× 402 3.0× 33 992
Jennifer M. Reiman United States 11 498 1.1× 377 1.2× 89 0.4× 131 0.6× 363 2.7× 13 939
Karen Bräutigam Germany 14 171 0.4× 345 1.1× 105 0.4× 190 0.9× 338 2.5× 32 916
Jill M. Wagner United States 18 494 1.1× 915 3.0× 118 0.5× 162 0.7× 180 1.3× 24 1.5k
Raghvendra M. Srivastava United States 11 649 1.4× 358 1.2× 136 0.6× 77 0.3× 426 3.2× 16 1.0k

Countries citing papers authored by Susan E. Yost

Since Specialization
Citations

This map shows the geographic impact of Susan E. Yost's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan E. Yost with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan E. Yost more than expected).

Fields of papers citing papers by Susan E. Yost

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan E. Yost. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan E. Yost. The network helps show where Susan E. Yost may publish in the future.

Co-authorship network of co-authors of Susan E. Yost

This figure shows the co-authorship network connecting the top 25 collaborators of Susan E. Yost. A scholar is included among the top collaborators of Susan E. Yost based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan E. Yost. Susan E. Yost is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kang, Irene, et al.. (2025). Clinical Actionability of Molecular Targets in Multi-Ethnic Breast Cancer Patients: A Retrospective Single-Institutional Study. Molecular Diagnosis & Therapy. 29(3). 393–405. 2 indexed citations
2.
Egelston, Colt A., Susan E. Yost, Paul Frankel, et al.. (2024). A phase I/II trial of palbociclib, pembrolizumab, and endocrine therapy for patients with HR+/HER2- locally advanced or metastatic breast cancer (MBC): Clinical outcomes and stool microbial profiling.. Journal of Clinical Oncology. 42(16_suppl). 1038–1038. 1 indexed citations
3.
4.
Egelston, Colt A., Weihua Guo, Susan E. Yost, et al.. (2023). Immunogenicity and efficacy of pembrolizumab and doxorubicin in a phase I trial for patients with metastatic triple-negative breast cancer. Cancer Immunology Immunotherapy. 72(9). 3013–3027. 14 indexed citations
5.
Behrendt, Carolyn E., Susan E. Yost, Niki Patel, et al.. (2023). Predicting Hyperglycemia Among Patients Receiving Alpelisib Plus Fulvestrant for Metastatic Breast Cancer. The Oncologist. 28(7). e488–e492. 5 indexed citations
6.
Wei, Christina, Evita Sadimin, Mark Agulnik, et al.. (2023). SMARCA4/BRG1-deficient Uterine Neoplasm With Hybrid Adenosarcoma and Carcinoma Features: Expanding the Molecular-morphologic Spectrum of SMARCA4-driven Gynecologic Malignancies. International Journal of Gynecological Pathology. 43(4). 354–361. 1 indexed citations
7.
Yuan, Yuan, Susan E. Yost, Yujie Cui, et al.. (2023). Phase I Trial of Ipatasertib Plus Carboplatin, Carboplatin/Paclitaxel, or Capecitabine and Atezolizumab in Metastatic Triple-Negative Breast Cancer. The Oncologist. 28(7). e498–e507. 9 indexed citations
8.
Epstein, Joel B., et al.. (2023). Oral Chronic Graft-versus-Host Disease in Post-Hematopoietic Stem Cell Transplant Patients Following SARS-CoV-2 Vaccination: Case Reports. SHILAP Revista de lepidopterología. 16(1). 1287–1292. 1 indexed citations
9.
Menghi, Francesca, Kalyan Banda, Pooja Kumar, et al.. (2022). Genomic and epigenomic BRCA alterations predict adaptive resistance and response to platinum-based therapy in patients with triple-negative breast and ovarian carcinomas. Science Translational Medicine. 14(652). eabn1926–eabn1926. 33 indexed citations
10.
Lavasani, Sayeh, George Somlo, Susan E. Yost, et al.. (2022). Phase 2 prospective open label study of neoadjuvant nab‐paclitaxel, trastuzumab, and pertuzumab in patients with HER2‐positive primary breast cancer. Cancer. 129(5). 740–749. 5 indexed citations
11.
He, Ting-Fang, Shawn T. Solomon, Travis Y. Tu, et al.. (2021). Spatial distribution of B cells and lymphocyte clusters as a predictor of triple-negative breast cancer outcome. npj Breast Cancer. 7(1). 84–84. 28 indexed citations
12.
Yuan, Yuan, Jin Sun Lee, Susan E. Yost, et al.. (2021). Phase I/II trial of palbociclib, pembrolizumab and letrozole in patients with hormone receptor-positive metastatic breast cancer. European Journal of Cancer. 154. 11–20. 61 indexed citations
13.
Reckamp, Karen L., Jasmine A. McQuerry, Isa Mambetsariev, et al.. (2020). Co-stimulatory and co-inhibitory Immune Markers in Solid Tumors With MET Alterations. Future Science OA. 7(2). FSO662–FSO662. 1 indexed citations
14.
He, Ting-Fang, Ruo‐Qian Wang, Daniel Schmolze, et al.. (2020). Occupancy and Fractal Dimension Analyses of the Spatial Distribution of Cytotoxic (CD8+) T Cells Infiltrating the Tumor Microenvironment in Triple Negative Breast Cancer. Biophysical Reviews and Letters. 15(2). 83–98. 2 indexed citations
15.
Yost, Susan E., et al.. (2019). Prolonged use of pegylated liposomal doxorubicin in gynecologic malignancies. Gynecologic Oncology Reports. 29. 89–93. 2 indexed citations
16.
Bolgiano, Barbara, Fatme Mawas, Susan E. Yost, et al.. (2001). Effect of physico-chemical modification on the immunogenicity of Haemophilus influenzae type b oligosaccharide–CRM197 conjugate vaccines. Vaccine. 19(23-24). 3189–3200. 29 indexed citations
17.
Lemercinier, Xavier, Christopher Jones, Michael J. Corbel, & Susan E. Yost. (1997). Analytical Procedures Used in the Control of Bacterial Glycoconjugate Vaccines. Pharmacy and Pharmacology Communications. 3(1). 19–23. 4 indexed citations
18.
Yost, Susan E., et al.. (1996). Molecular size characterization of Haemophilus influenzae type b polysaccharide-protein conjugate vaccines. Vaccine. 14(5). 399–404. 19 indexed citations
19.
Yost, Susan E., et al.. (1995). Flanking and Intragenic Sequences Regulating the Expression of the Rabbit α-Globin Gene. Journal of Biological Chemistry. 270(8). 3965–3973. 16 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tetsuhiko Asao Breakdown of academic impact, for papers by Wenzheng Guo Breakdown of academic impact, for papers by Colt A. Egelston Breakdown of academic impact, for papers by Arnold I. Chin Breakdown of academic impact, for papers by Jennifer M. Reiman Breakdown of academic impact, for papers by Karen Bräutigam Breakdown of academic impact, for papers by Jill M. Wagner Breakdown of academic impact, for papers by Raghvendra M. Srivastava
Rankless by CCL
2026